We investigated the clinical significance of brain natriuretic peptide (BNP), a cardiac hormone, in chronic obstructive pulmonary disease (COPD). Subjects were 38 patients with stable COPD, of whom 20 had cor pulmonale (CP), and 22 were healthy individuals. Plasma BNP levels were measured and pulmonary arterial pressure (PAP) was estimated by echocardiography. Arterial blood gas analysis, forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) were also recorded. BNP levels of patients with COPD were higher than those of controls (48.2 ± 37.5 and 9.3 ± 3.0 pg/ml). Patients with CP had a higher mean BNP level with respect to those without CP (73.9 ± 35.8 and 21.0 ± 10.2 pg/ml, respectively). BNP levels correlated with PAP (r = 0.68), partial arterial oxygen pressure (r = −0.70), FEV1 (r = −0.65) and FVC (r = −0.52). We have concluded that BNP determination has a role in the diagnosis of CP in patients with COPD.
CoultasDBMapelDGagnonRLydickE: The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med2001; 164: 372–377.
SaitoYNakaoKItohHYamadaTMukoyamaMAraiH: Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun1989; 158: 360–368.
5.
SudohTKangawaKMinaminoNMatsuoH: A new natriuretic peptide in porcine brain. Nature1988; 332: 78–81.
6.
KambayashiYNakaoKMukoyamaMSaitoYOgawaYShionoS: Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett1990; 259: 341–345.
7.
PesolaGR: The use of B-type natriuretic peptide (BNP) to distinguish heart failure from lung disease in patients presenting with dyspnea to the emergency department. Acad Emerg Med2003; 10: 275–277.
8.
BandoMIshiiYSugiyamaYKitamuraS: Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med1999; 93: 507–514.
9.
CargillRILipworthBJ: Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects. Chest1996; 110: 1220–1225.
10.
WieczorekSJWuAHChristensonRKrishnaswamyPGottliebSRosanoT: A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation. Am Heart J2002; 144: 834–839.
11.
MiyatakeKOkamotoMKinoshitaNOhtaMKozukaTSakakibaraH: Evaluation of tricuspid regurgitation by pulsed Doppler and two-dimensional echocardiography. Circulation1982; 66: 777–789.
12.
NakaoSComePCMcKayRGRansilBJ: Effect of positional changes on inferior vena caval size and dynamics and correlations with right-sided cardiac pressure. Am J Cardiol1987; 59: 125–132.
13.
KnudsonRJSlatinRCLebowitzMDBurrowsB: The maximal expiratory flow volume curve: Normal standards, variability, and effects of age. Am Rev Respir Dis1976; 113: 587–600.
14.
de DenusSPharandCWilliamsonDR: Brain natriuretic peptide in the management of heart failure: The versatile neurohormone. Chest2004; 125: 652–668.
15.
LangCCCoutieWJStruthersADDhillonDPWinterJHLipworthBJ: Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond)1992; 83: 529–533.
16.
ten WoldeMTulevskiIIMulderJWSohneMBoomsmaFMulderBJ: Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation2003; 107: 2082–2084.
17.
FujiiTOtsukaTTanakaSKanazawaHHirataKKohnoM: Plasma endothelin-1 level in chronic obstructive pulmonary disease: Relationship with natriuretic peptide. Respiration1999; 66: 212–219.
18.
MaederMAmmannPRickliHDiethelmM: Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med Wkly2003; 133: 515–518.
